GB

Akubio Limited

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 20.0

Forward Citations = 340

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Victor Petrovich Ostanin (4 out of 7 patents)

silverMedal Daniel Peterson Godfrey (2 out of 12 patents)

bronzeMedal David Klenerman (2 out of 9 patents)

4.  Fedor Nikolaievich Dultsev (2 out of 3 patents)

5.  Frank Paul (2 out of 2 patents)

6.  Richard C Payne (2 out of 2 patents)

7.  Karl David Pavey (1 out of 2 patents)

8.  Alexander Sleptsov (1 out of 2 patents)

9.  Herbert Thanner (1 out of 7 patents)

10.  Mark John Frogley (1 out of 2 patents)

11.  Klaus Wiehler (1 out of 4 patents)

12.  Julian Paul Abbott (1 out of 1 patent)

13.  Karl Pavey (1 out of 1 patent)

14.  Peter W Krempl (1 out of 24 patents)

15.  Lucy Sheldon (1 out of 1 patent)


10 patents:

Company Overview
Akubio Limited is a biotechnology company based in Great Britain, specializing in the development of innovative solutions for the life sciences sector. The organization focuses on advancing research and diagnostics through cutting-edge technologies, particularly in areas such as molecular biology and genetic analysis. By leveraging its expertise, Akubio aims to enhance the efficiency and accuracy of scientific research, contributing to the broader field of healthcare and biological sciences.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 17 2026

10 Patents

#113 in

#1,737 in United Kingdom

#56,291 in the World

GB
GB
Forward Citations = 340

15 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Akubio Limited. Retrieved from https://idiyas.com/company/akubio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…